| 1 |
34328594 | Innovative treatment targeting gangliosides aimed at blocking the formation of neurotoxic α-synuclein oligomers in Parkinson's disease. | 2022 Feb |
4 |
| 2 |
34768981 | Gene Therapy Strategy for Alzheimer's and Parkinson's Diseases Aimed at Preventing the Formation of Neurotoxic Oligomers in SH-SY5Y Cells. | 2021 Oct 26 |
2 |
| 3 |
30878495 | Reprint of "Ganglioside lipids accelerate α-synuclein amyloid formation". | 2019 May |
1 |
| 4 |
31698188 | GM1 Ganglioside role in the interaction of Alpha-synuclein with lipid membranes: Morphology and structure. | 2019 Dec |
3 |
| 5 |
29632069 | Extracellular α-synuclein drives sphingosine 1-phosphate receptor subtype 1 out of lipid rafts, leading to impaired inhibitory G-protein signaling. | 2018 May 25 |
1 |
| 6 |
30077783 | Ganglioside lipids accelerate α-synuclein amyloid formation. | 2018 Aug 2 |
1 |
| 7 |
27261254 | Gangliosides of the Vertebrate Nervous System. | 2016 Aug 14 |
1 |
| 8 |
27352802 | Common molecular mechanism of amyloid pore formation by Alzheimer's β-amyloid peptide and α-synuclein. | 2016 Jun 29 |
1 |
| 9 |
24903509 | Pathogenic role of ganglioside metabolism in neurodegenerative diseases. | 2014 Oct |
1 |
| 10 |
25140899 | Deciphering the glycolipid code of Alzheimer's and Parkinson's amyloid proteins allowed the creation of a universal ganglioside-binding peptide. | 2014 |
2 |
| 11 |
23775688 | The driving force of alpha-synuclein insertion and amyloid channel formation in the plasma membrane of neural cells: key role of ganglioside- and cholesterol-binding domains. | 2013 |
2 |
| 12 |
21396938 | Molecular basis for the glycosphingolipid-binding specificity of α-synuclein: key role of tyrosine 39 in membrane insertion. | 2011 May 13 |
1 |
| 13 |
20114052 | Altered ion channel formation by the Parkinson's-disease-linked E46K mutant of alpha-synuclein is corrected by GM3 but not by GM1 gangliosides. | 2010 Mar 19 |
2 |
| 14 |
17253773 | GM1 specifically interacts with alpha-synuclein and inhibits fibrillation. | 2007 Feb 20 |
3 |